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Rift Valley Fever Virus (RVFV) is the causative agent of Rift Valley Fever (RVF), transmitted either by 
hematophagous insects that infect animals and humans or by direct contact with infected animals. This 
study was performed to preparing RVF antigen from liver of infected lamb to be used in detecting 
anti-RVFV antibodies by using Enzyme Linked immunosorbent assay (ELISA) and to study 
epidemiological prevalence of anti-RVFV IgM and IgG antibodies among animals which conducted in 
the Researches Center of Taiz University and Central Health Laboratory, Taiz Governorate, 
Southwestern Yemen. RVFV antigen was successfully prepared at a titer dilution of 1: 3200 by 
Chessboard (CB) ELISA assay. However, out of 188 samples, 147 samples were positive for ELISA 
assay, of which 12 (8.2 %) were positive for anti-RVFV IgM and 135 (91.8 %) for anti-IgG antibodies. 
The antigen was successfully produced, and successfully adhered to ELISA plates. Simple and 
inexpensive methods give good results. The results can be used to develop and refine predictive database 
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Rift Valley Fever (RVF) is a re-emerging viral vector-borne disease caused by Rift Valley Fever Virus 
(RVFV) with rapid global socio-economic impact, a member of family Bunyaviridae genus 
Phlebovirus that affects domestic ruminants and humans [1]. In ruminants, it induces almost 100% 
mortality among young animals, a high rate of abortion in pregnant females, and is responsible on 
listlessness, fetid, unsteady gait, reluctant to stand, bloody diarrhea, abortion, liver necrosis and death 
[2, 3]. In humans, severity of infection can vary from mild to very severe clinical symptoms, 
including fever, blindness, encephalitis, and hemorrhagic fever with a fatal outcome [2,4]. It is 
transmitted by mosquitoes, direct contact with infected animal tissues and products [5].  
 RVF is an endemic disease in Africa and the Arabian Peninsula, the outbreak was appeared for 
the first time in the Saudi Arabia and Yemen in 2000 – 2001. In Saudi Arabia, reported 11,882 human 
cases with 164 deaths [6,7,8]. In Yemen, reported 1080 human cases and 141 deaths [7,8,9], over 
20.000 abortion animals and 620 dead [7,10]. Several outbreaks were followed after heavy rainfall in 
Egypt, Kenya, Somalia, Tanzania, Sudan, Mayotte, and Mauritania from 2003 to 2012 [11]. 
 There are several methods that are used in RVF diagnosis, Scott, et al. [12] determined that the 
accuracy of serological methods in detecting anti-RVFV antibodies was indicated that Enzyme Linked 
immunosorbent assay (ELISA) was the most precise of the other serological methods, so this study 
aimed to preparing RVF antigen from liver of infected lamb to be used in detecting anti-RVFV 
antibodies by using modern ELISA technique and to study epidemiological prevalence of anti-RVFV 
IgM and IgG antibodies among domestic animals, and establishment primary database of RVF 
prevalence in Yemen. 
Materials and Methods     
This study enrolled a total of 188 animals that suffered from sickish collected from stockyards and 
fields of Taiz Governorate, Southwestern Yemen, aged from 2 months to over than 3 years which 
included sheep, goats and cattle, during the period from January 2013 until August 2016. About 5 ml 
of blood were collected by venipuncture into sterile tube, allowed to clot, centrifuged (2000 rpm, 10 
min) for separation of serum, transferred into new sterile tube, inactivated in water bath at 56˚С for 30 
minutes, and stored in refrigerator at -20 ˚С until used by ELISA [13,14].  
Preparation of RVFV antigen  
According to the information mentioned by Smithburn, et al. [15] the concentration of RVFV was 
highest in the liver of infected animal. Based on this data, RVFV antigen was prepared from liver of 
lamb by using sucrose acetone extraction method according to methods described by Clarke and 
Casals [16]. 
Lamb inoculation, two lambs aged 2 and 4 months, were inoculated intraperitoneally with 0.5 ml 
of infected human serum by RVFV containing 104 LD50 (it was kindly supplied by the Department of 
Virology, Central Researches laboratories, Taiz Governorate) for each under strict control measures. 
Sufficient virus was present in serum of lambs after 4 days of inoculated, and the titer of virus in the 
serum was 1600 when it seemed unsteady gait. No any lamb died during the virus incubation period. 
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Procedure for lamb liver derived sucrose acetone extracted RVFV antigen, 10g of infected lamb 
Liver was put in sterile mortar, and thoroughly minced. Four volumes of 8.5% aqueous solution of 
sucrose (after sterilized by filtration) were added to the liver tissue, and mixed well until homogenized. 
One volume of homogenate was added to 20 ml of chilled acetone after vigorous shaking. The tightly 
stoppered bottles were centrifuged at 1800 rpm for 5 minutes at 4˚С. The supernatant fluid was 
aspirated, and chilled acetone equal to the aspirated amount was added to the sediment. The bottles 
were placed in an ice bath for at least one hour to dehydrate the gummy sediment. The centrifugation 
process was repeated two times, and the supernatant was aspirated and completed drying the sediment 
by attaching vacuum pump through a filter flask to the bottle containing the sediment. Normal saline 
was added to the dried sediment in a volume equal to 0.4 volume of the original volume of the 
homogenate. The sediment was dissolved within 2 hours, and the solution was left overnight in 
refrigerator. After complete dissolving, the solution was centrifuged in a refrigerated centrifuge at 
20,000 rpm for at least 30 minutes. The supernatant containing the viral antigen was inactivated with 
binary (20% sodium thaiosulphate solution sterilized by autoclaving, used to neutralize the 
2-Bromoethylamine hydrobromide action), kept in a bottle and frozen at -70˚С until used.  
Serological examination    
Chessboard (CB) titration ELISA Procedures for the prepared antigen was done according to Rose et 
al. [17]. The prepared antigen was subjected to evaluation of the binding activity against specific 
antibody molecules IgM, IgG, and subjected to serial 2-fold dilution in coating buffer 
(carbonate-bicarbonate, pH 9.6) as is described in the Annex, to obtain dilutions of 1:50; 1:100; 1:200; 
1:400 … etc. Row H was left empty as blank. 50 μl of each dilution was dispensed into horizontal 
rows A-G wells in polystyrene microtiter plates (Maxisorp; Nunk, Copenhagen, Denmark, plates), 
incubated overnight at 4˚С, washed 4 times by washing buffer. 50 μl/well of blocking buffer was 
dispensed to all wells, incubated for 1h at 37 ˚С, washed 4 times. Two reference sera (strong positive 
and known negative) were diluted 2-fold 1:10; 1:20; 1:40 and so on in diluting buffer.  50 μl of each 
dilution was added to vertical columns (1-10) while the columns (11-12) received 50 μl of the known 
negative serum sample, incubated at 37˚С for (1 h in titer IgG or 2 h in IgM), washed 4 times. 50 µl of 
diluted horseradish peroxidase conjugated anti-species (anti-sheep, anti-cattle and anti-goat) IgG or 
IgM (Sigma Chemical Co.) was added to all wells, incubated (1 h in 37˚С), washed 4 times. The 
substrate buffer was added to all test wells (50 µl / well), incubated at 37˚С in dark place for 20 
minutes. 50 µl of stopping buffer was added to all wells. The optical density was measured at 492 nm 
using plate readers. The highest dilution of antigen was done a value of 1.2 after 20 minutes of 
substrate incubation with the strong positive serum antibodies IgG while done a value of 1.3 with the 
strong positive serum antibodies IgM, and under 0.1 with negative serum was considered the optimal 
dilution of the antigen. 
ELISA procedures for detection of anti-RVFV IgM and IgG antibodies was done according to 
Voller et al. [18]. The serum samples were analyzed for detecting anti-RVFV IgM and IgG antibodies 
by using indirect ELISA assay. Ninety-six well polystyrene microtiter plates (Cooke M 29 AR; 
Dynatech plates) were coated with 100 µl/well (Row H wells were left empty as blank) of RVFV 
antigen diluted in coating buffer, covered, incubated at 4˚С overnight, washed 3 times using washing 
buffer. 100 μl/well of blocking buffer was dispensed to all wells, incubated for 1h in moist chamber at 
37 ˚С for 30 minutes, washed 3 times. Serum samples were diluted (1:10 for test IgG or 1:40 for IgM) 
in diluting buffer, and 100 µl of each serum sample was added in duplicate. Each plate included a 
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positive control serum (wells A1-A6) and a negative control serum (wells A7-A12). Plates were 
incubated at 37 ˚С for (1 h in test IgG or 2 h in IgM). After being washed 3 times, 100 µl of 
horseradish peroxidase conjugate labeled anti-species (whole molecules of IgG or IgM diluted 
according to the manufacturer’s recommendation, Sigma Chemical Co.) was added into each well, 
and incubated (1h in 37 ˚С). The plates were washed 3 times, and blotted on paper towels. 100 µl/well 
of orthophenylenediamine hydrochloride substrate was added, and plates leaved for 20 minutes at 37 
˚С in dark. The reaction was stopped through 10 minutes after adding 50 µl /well of stopping buffer. 
The plates were read by ELISA using dynatech plate reader at 492 nm. The samples with optical 
density values greater than three standard deviation (3SD) above the mean of the negative control 
serum samples (Cutt-off) were considered positive. 
      Cutt-off = X͞   + 3SD 
      X͞   = mean of negative control serum samples. 
      SD= standard deviation of negative control serum samples. 
Statistical analysis 
Statistical analyses of the data were performed using statistical software package SPSS version 16. 
The categorical variables were done using Chi-square test at a 99% confidence level, and a 
significance level of 0.05 was used to determine the relationships between the data collection and 
epidemiological prevalence rates. Asymptotic Significance ≤ 0.05 was considered to be significant. 
Ethical approval 
Ethical approval for this study was granted by the Microbiology Division, Biology Department, 
Faculty of Science, Sana'a University Ethical Committee. Permission to conduct the study was sought 
from Sana'a to Taiz Governorate authorities. Oral and written consent was obtained from all 
participants' farmers, stockyards' owners, or Shepherds.  
Results 
The prepared antigen from liver of lamb was successfully produced, and titrated by using specific 
IgM and IgG antibodies through CB ELISA titration assay. However, the highest titer dilution was 
investigated 1: 3200 by using CB titration ELISA assay for both IgM and IgG antibodies. 
Out of 188 samples (54 cattle, 97 sheep, and 37 goats), 147 (78.2%) were positive for ELISA 
assay, and 41 (21.8%) were negative. However, the overall positive results rate 135 (71.8%) were 
positive for IgG (38 cattle, 75 sheep, 22 goat) while 12 (8.2%) were positive for IgM (3 cattle, 7 sheep, 
2 goat). The epidemiological prevalence rate of anti-RVFV IgM and IgG among animals is shown in 
Table 1. Results are revealed that RVFV was equally targeted the age groups < 1 year, 1-2 years and 
the prevalence rate of anti-IgM was 6 (50%) in both. On the other hand, the highest prevalence rate 
was 70 (51.9%) in age group 1-2 years of anti-RVFV IgG and decreased to 36 (26.1%) in age group < 
one year. However, the highest prevalence rate was 7 (58.3%) and 75 (55.6%) in sheep of anti-IgM 
and IgG respectively. However, the relationship among age groups and immunity response to IgM and 
IgG are not significant > 0.05.  In general, rate of males was higher than females. So, 82 (60.7 %) 
and 7 (58.3 %) of cases were males more infected than females 5 (41.7%) and 53 (39.3%) of anti-IgM 
and IgG respectively. The relationship amongst sex, RVFV infection, and immunity response of the 
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animals is shown a statistical significant < 0.05. 
Actually, the highest epidemiological distribution rate of anti-RVFV cases among animals 
according to clinical signs and species is shown in Table 2. The highest epidemiological distribution 
rate was found 82 (55.8%) in sheep, decreased to 41 (27.8%) in cattle and 24 (16.4%) in goats. 
However, the sheep were the most affected in RVFV, followed by cattle and goats. In additional, 
among the 147 cases, of which 54 (36.7%) were had listlessness, 42 (28.6%) unsteady gait, 18 
(12.2%) blindness which recorded for the first time in Yemen, 21 (14.3%) reluctant to stand, and 12 
(8.2%) of cases had abortion. The relationship between clinical signs, species of animal, and 
immunity response is significant < 0.05. However, the results revealed that the highest 
epidemiological distribution rate were demonstrably appeared 63 (42.9%) in autumn and decreased to 
48 (32.7%) in summer. Therefore, the prevalence rate was decreasingly started at end of autumn and 
dramatically increased at end of spring. The relationship among immunity response for the animals, 
RVFV infection, and seasons of year is not occurred statistical significant > 0.05. 
 
Table 1 Epidemiological prevalence rate of IgM and IgG among animals in relation to age groups and sex 
 
Variables 


















Age Groups         
< 1 1 (8.3) 5 (41.7) 0 (0.00) 6 (50.0) 13 (9.4) 19 (13.8) 4 (2.9) 36 (26.1) 
1-2 2 (16.7) 2 (16.7) 2 (16.7) 6 (50.0) 16 (11.9) 43 (31.9) 11 (8.1) 70 (51.9) 
2-3 0 0 0 0 6 (4.4) 8 (5.9) 5 (3.7) 19 (14.1) 
> 3 0 0 0 0 3 (2.2) 5 (3.7) 2 (1.5) 10 (7.4) 
Total 3 (25.0) 7 (58.3) 2 (16.7) 12 (100) 38 (28.1) 75 (55.6) 22 (16.3) 135 (100) 
P-Value 0.186 0.981 
df 1 1 
Asymp. Sig. 0.666 0.322 
Sex         
Males 2 (16.7) 4 (33.3) 1 (8.3) 7 (58.3) 12 (8.9) 56 (41.5) 14 (10.4) 82 (60.7) 
Females 1 (8.3) 3 (25.0) 1 (8.3) 5 (41.7) 26 (19.3) 19 (14.1) 8 (5.9) 53 (39.3) 
P-Value 0.133 9.838 
df 1 1 
Asymp. Sig. 0.715 0.002 
 
No.: Number of cases; Symp. Sig.: Asymptotic Significance; df: Degree of Freedom; P-Value: Possibility Value. 
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Table 2 Epidemiological distribution of RVFV among animals in relation to clinical signs and season  






No. (%) P-Value df Asymp. Sig. 
Clinical signs        
Listlessness 26 (17.7) 20 (13.6) 8 (4.5) 
54 (36.7) 
5.007 1 0.025 
Blindness 0 (0.00) 18 (12.2) 0 (0.00) 
18 (12.2) 
Unsteady gait 9 (6.1) 21 (14.3) 12 (8.2) 
42 (28.6) 
Reluctant to stand 3 (2.0) 16 (10.9) 2 (1.4) 
21 (14.3) 
Abortion 3 (2.0) 7 (4.8) 2 (1.4) 
12 (8.2) 
Total 41 (27.9) 82 (55.8) 24 (16.3) 
147 (100) 
   
Season        
Summer 13 (8.8) 25 (17.0) 10 (6.8) 48 (32.7) 
0.297 1 0.586 
Autumn 18 (12.2) 35 (23.8) 10 (6.8) 63 (42.9) 
Winter 3 (2.0) 8 (5.4) 0 (0.00) 11 (7.5) 
Spring 7 (4.8) 14 (9.5) 4 (2.7) 25 (17.0) 
No.: Number of cases; Symp. Sig.: Asymptotic Significance; df: Degree of Freedom; P-Value: Possibility 
Value. 
Discussion  
This study was performed to preparation RVF antigen to be used in detecting anti-RVFV antibodies in 
animals or human's serum samples by using modern ELISA technique and to study epidemiological 
prevalence of anti-RVFV IgM and IgG among domestic animals. 
However, the prepared antigen from lamb liver was successfully prepared using sucrose acetone 
extraction technique, and also assessed successfully by IgM and IgG antibodies. This antigen was 
successfully adhered to CB ELISA plates directly at a highest titer dilution of 1: 3200. This is in 
consistent with those recorded by Said [19] who produced same antigen from the liver of sheep at a 
dilution of 1: 200. Similar antigen prepared by Paweska, et al. [20] from infected mouse liver at a 
dilution of 1: 400. Moreover, Maysa [21] prepared RVFV antigen from the liver of hamster at a 
dilution of 1:3200. From the mentioned above, the difference in titration results may be related to 
 
 Ivy Union Publishing | http: //www.ivyunion.org   ISSN 2572-5815               January 22, 2019 | Volume 7 | Issue 1  
 




variance in methods of test, accuracy and sensitivity of test.   
The present study showed that 147 out of 188 cases were positive for ELISA assay their ages 
ranged from < one year to over than 3 years. However, the overall epidemiological prevalence rate of 
anti-RVFV IgM was 8.2% (12 out of 147). Nearly similar results were previously reported by 
Thonnon, et al. [22] who found of 12.5% during their survey in Senegal. Moreover, the highest 
epidemiological prevalence rates of 16.67%, 34.8% and 100% were recorded respectively by Zeller, et 
al. [23], Nabeth, et al. [24] and Pepin, et al. [25] whose collected their samples from affected herd 
after RFV outbreak, but the lowest prevalence rate was recorded by Paweska, et al. [20] who recorded 
0.28% were seropositive against RVFV in both sheep and goats. On the other hand, the overall 
epidemiological prevalence rate of anti-RVFV IgG antibodies was 91.8% (135 out of 147). Lower 
prevalence rate of 18.7%, 50% (7 of 14), 40%, 14.5%, 20.95% and 14.9% were previously recorded 
by Zeller, et al. [23], Joshi, et al. [26], Thonnon, et al. [22], Youssef [27], Mysa, [21], and Byomi, et al. 
[28] whose collected their samples after epizootic outbreak respectively. The difference in results 
between this study and the comparable one are may attributed to difference in the health status of the 
animals, variance in sample size, specificity of test and low concentration of the antibodies in the 
serum samples. 
The highest epidemiological prevalence rate of anti-IgM was equally recorded 6 (50%) in both 
age group ranging from 1-2 years and < 1 year. This is in disagreement with Zeller, et al. [23] and 
Qlaleye, et al. [29] whose recorded that the prevalence rate in the age group > 2 years and over than 
the 3 years was higher than that in the age group < 2 years and in the < 3 years old respectively, and 
may be related to lower in our chosen animals or samples than the other one. In contrary to this, the 
higher epidemiological prevalence rate of anti-IgG was 51.9% in age group ranging from 1-2 years 
then 26.7% in age group < one year, this is in disagreement with Zeller, et al. [23], Qlaleye, et al. [29] 
and Youssef [27] who recorded that animals over 2 years and over 3 years had a higher prevalence of 
antibodies to RVF. They may be collected most of their samples from animals aged two years or more. 
However, the difference in results may be related to that we collected our samples from animals met 
the case defined of acute RVF infection. Therefore, there was a significant difference between age 
groups and immunity response of animals > 0.05.   
The results also revealed that the overall epidemiological prevalence rate of anti-RVFV IgM 
cases in sheep 58.3% was higher than that recorded by Paweska, et al. [20] and Nabeth, et al. [24] 
whose recorded 0.16% and 34.8% respectively. On the other hand, higher percentage than that 
recorded in this study was reported by Pepin, et al. [25] who obtained 99.75% of IgM antibodies in 
sheep. However, the overall prevalence rate of anit-IgG cases was 55.6% in sheep. Nearly similar to 
those recorded by Youssef [27] who recorded 33.5%. In contrary to this, lower prevalence rate of 
21.1%, 26.74% and 21.4% was recorded by Youssef [27], Mysa, [21] and Byomi, et al. [28]. On the 
other hand, higher prevalence rate 97.3% was recorded by Pepin, et al. [25].  As mentioned above, 
the sheep are the most sensitive animals and susceptible to RVF. 
Regarding sex. the overall epidemiological prevalence rate of anti-IgM in males and females was 
58.3% and 41.7% respectively. The higher prevalence rate in males than females may be related to the 
breeding purpose of animals Yedloutschnig, et al. [30]. Moreover, the overall prevalence rate of 
anti-IgG 60.7% in males was higher than females 39.3%. In opposition to this, Youssef [27], Mysa, 
[21] and Byomi, et al. [28] who found that rate of males 12%, 13.54% and 8.6% was lower than 
females 15.6%, 50% and 17.7% respectively. This difference in the results may be related to the fact 
that lactating and breeding females are reared for older ages than males so they are more liable to 
contract the infection more than males. Incidentally, the males are more involved than females in this 
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study. Obviously, there was a statistical significant amongst gender, RVFV infection, and immunity 
response of animals < 0.05. 
The epidemiological distribution rate of anti-RVFV cases according to clinical signs and species 
revealed that the higher distribution rate 36.7% accompanied with listlessness, 28.6% associated with 
unsteady gait and 14.3% reluctant to stand. On the other hand, the lower distribution rate 8.2% 
associated with abortion and 12.2% blindness in sheep. However, the blindness phenomenon is 
recently shown in Yemen, and is no recorded in any previous study. The abortion in sheep and goats is 
in a consistence with Byomi, et al. [28] who proved that RVF play an important role in abortions 
especially in sheep and goats. There was a statistical significant among clinical signs, RVFV infection, 
and immunity response of animals < 0.05. 
The highest epidemiological distribution rate of anti-RVFV antibodies recorded 63 (42.9%) and 
48 (32.7%) in autumn and summer respectively. These findings are in agreement with Qlaleye, et al. 
[29] who was mentioned that the infection rate was significantly higher during the wet season than 
during the dry season of the same year. This is in consistent with Mysa [21], who recorded lower 
prevalence rate was 20% in Summer, 7.14% in Autumn. The difference in results may be attributed to 
the environmental factors, vegetation, rainfall, slope degree, abundance of vectors and selected 
specimens. There was a significant difference between seasons of year and immunity response of 
animals > 0.05.  
Conclusion 
The prepared antigen was successfully produced and successfully adhered to ELISA plates at a 
highest titer dilution of 1: 3200. Simple, inexpensive methods give good results. However, out of 188 
samples, 147 samples were positive for ELISA assay, of which 12 (8.2 %) were positive for 
anti-RVFV IgM and 135 (91.8 %) for anti-IgG antibodies. Epidemiological prevalence of RVF among 
animals would be the highest in Autumn and in Summer, especially during rainfall and Greater Feast. 
The most affected animals by RVFV are the sheep, 12.2% of the sheep is blinded. On the other hand, 
the most infected animals are having age group below 2 years, and the males are more infected than 
females. Apparently healthy animals may be a source of infection, so care must be taken during 
contact with liver and spleen of any animals. The result can be used to develop and refine predictive 
database for RVF transmission based on environmental and remote sensing data. 
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1. Phosphate buffer saline (PBS): 
             It was composed according to Voller, et al., 1976 as follows: 
Sodium chloride NaCl …………………………………….……... 8.00 g                                                 
Potassium chloride KCl …………………………..……............. 0.20 g 
Potassium dihydrogen phosphate KH2PO4……….…….. 0.20 g 
Disodium hydrogen phosphate Na2HPO4.12H20……… 2.90 g 
Distilled water …………………………………………..…………. 1000 ml    
pH…………………………………………………………………….…... 7.4 
 
2. Coating buffer (carbonate-bicarbonate buffer, pH 9.6):  
Sodium bicarbonate (NaHCO3)……………….……..….. 2 .93g 
Disodium carbonate (Na2CO2)…………..………..…...... 1.59g 
Distilled water.…………...…………………………………..... 1000ml 
pH………………………………………………………………...….. 9.6 
 
3. Diluting buffer, it was composed of 5g of bovine serum albumin, 50 µl tween 20, in 1-liter 
BPS. 
4. Blocking buffer, it was prepared of 10g bovine serum albumin in 1-liter BPS. 
5. Washing buffer, it was composed of 0.5 ml tween 20 in 1-liter BPS. 
6. Conjugate, it was horse reddish peroxidase labeled anti-species whole molecules IgG and 
IgM (Sigma Chemical Co.). 
7. Substrate buffer (Phosphate citrate buffer): 
 
 
 8. Stopping buffer, it was composed of 2.5M sulfuric acid (H2SO4), pH 3.3 and used for 
stopping the enzymatic reaction on ELISA substrate.      
 
 
0.1M Citric acid (2.1 g in 100 ml distilled water)……...… 24.3 ml 
Na2HPO4 (7.1 g  in 100 ml Distilled water ………...……….. 25.7 ml 
Distilled water …………………...…………………………………..... 50 ml 
Orthophenylenediamine ……….………………………………….. 40 mg 
H2O2....................................................................................................... 20 µl 
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